- Current report filing (8-K)
April 12 2012 - 12:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
April 10, 2012
Date of Report (date of earliest event reported)
SOLTA MEDICAL,
INC.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-33123
|
|
68-0373593
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
25881 Industrial Boulevard, Hayward, California 94545
(Address of principal executive offices)
(510) 782-2286
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
(a) On April 10, 2012, the board of directors (the
Board
) of Solta Medical, Inc. (the
Company
) amended Section 3.3 of the Companys Amended and Restated Bylaws (the
Bylaws
) to change the voting standard for the election of directors in uncontested elections from a
plurality to a majority of the votes cast. A majority of the votes cast means that the number of shares voted for a director must exceed the number of shares voted against the director. In conjunction with the bylaw amendment, the Board also
approved amendments to the Companys Corporate Governance Guidelines to provide that each director submit in writing an advance, contingent, irrevocable resignation that the Board may accept if stockholders do not re-elect that director. In
that were to occur, within 90 days after the date of the certification of the election results, the Nominating and Governance Committee would determine whether to accept or reject the resignation and submit such recommendation for prompt
consideration by the Board.
The preceding description of the amendment to the Companys Bylaws is qualified in its
entirety by reference to the Companys Bylaws, which are attached hereto as Exhibit 3.1 and are incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Number
|
|
Description
|
|
|
3.1
|
|
Amended and Restated Bylaws of the Company.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
SOLTA MEDICAL, INC.
|
|
|
|
Date: April 12 , 2012
|
|
By:
|
|
/s/ John F. Glenn
|
|
|
|
|
John F. Glenn
|
|
|
|
|
Chief Financial Officer
|
3
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jul 2023 to Jul 2024